Molecule Known to Slow Inflammation Linked to Scleroderma, Could Be Treatment Target

January 31, 2023


Read time:

5-15 mins
Presented by Health Lab

Scleroderma is an autoimmune disease that causes a buildup of scar tissue on organs. A study conducted suggests that scleroderma patients have reduced expression of the A20 molecule, which normally prevents the formation of fibrosis. But this altered A20 expression or function in scleroderma contributes to fibrosis. John Varga, MD., professor of rheumatology, discusses the importance of the A20 molecule and how it has not been linked to scleroderma until now.

More from the Alumni Education Gateway
Join the Alumni Education Gateway Email List​
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.